Breaking News

Sartorius Expands Capacity

Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas. A new plant will be built in the industrial zone in Guxhagen, Germany. The new building will be approximately 93,000 sq. ft., providing 50% more office and production space. The cost of the project will be approximately 14 million euros. Construction is scheduled to begin in the spring of 2011 with a relocation date scheduled for 1Q12.

Managing director Hans-Peter Casel remarked, “We are happy to have found such a capable partner and investor for our building project as Robos. The new building complex in Guxhagen will create entirely new production conditions. It will enable us to significantly optimize our process operations and enhance collaboration among our individual departments and units. Moreover, the new site is also a good solution for our employees, most of whom live in the region.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters